Please enter the email address you used to register, then we will send you a link to choose a new password
- 8K Filing
Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azaciti...
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein d...